NO904511L - Pyrimidine. - Google Patents

Pyrimidine.

Info

Publication number
NO904511L
NO904511L NO90904511A NO904511A NO904511L NO 904511 L NO904511 L NO 904511L NO 90904511 A NO90904511 A NO 90904511A NO 904511 A NO904511 A NO 904511A NO 904511 L NO904511 L NO 904511L
Authority
NO
Norway
Prior art keywords
pyrimidine
Prior art date
Application number
NO90904511A
Other languages
Norwegian (no)
Other versions
NO176758C (en
NO904511D0 (en
NO176758B (en
Inventor
Peter Herold
Peter Buehlmayer
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO904511D0 publication Critical patent/NO904511D0/en
Publication of NO904511L publication Critical patent/NO904511L/en
Publication of NO176758B publication Critical patent/NO176758B/en
Publication of NO176758C publication Critical patent/NO176758C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO904511A 1989-10-19 1990-10-18 Analogous Process for Preparing Therapeutically Useful Tetrazolyl-Biphenylyl Methyl-Pyrimidines NO176758C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH379989 1989-10-19

Publications (4)

Publication Number Publication Date
NO904511D0 NO904511D0 (en) 1990-10-18
NO904511L true NO904511L (en) 1991-04-22
NO176758B NO176758B (en) 1995-02-13
NO176758C NO176758C (en) 1995-05-24

Family

ID=4263704

Family Applications (1)

Application Number Title Priority Date Filing Date
NO904511A NO176758C (en) 1989-10-19 1990-10-18 Analogous Process for Preparing Therapeutically Useful Tetrazolyl-Biphenylyl Methyl-Pyrimidines

Country Status (14)

Country Link
EP (1) EP0424317A3 (en)
JP (1) JPH03133964A (en)
KR (1) KR910007889A (en)
AU (1) AU638496B2 (en)
CA (1) CA2027839A1 (en)
FI (1) FI93957C (en)
HU (1) HUT55383A (en)
IE (1) IE903749A1 (en)
IL (1) IL96009A0 (en)
MX (1) MX22877A (en)
NO (1) NO176758C (en)
NZ (1) NZ235726A (en)
PT (1) PT95626A (en)
ZA (1) ZA908344B (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05505609A (en) * 1990-03-30 1993-08-19 メルク・エンド・カムパニー・インコーポレーテツド Substituted pyrimidines, pyrimidinones and pyridrimidines
US5324729A (en) * 1990-03-30 1994-06-28 Merck & Co., Inc. Substituted pyrimidines, pyrimidinones and pyridopyrimidines
AU653734B2 (en) * 1990-06-19 1994-10-13 Meiji Seika Kabushiki Kaisha Substituted 4-biphenylmethoxypyridine derivatives
IL99246A0 (en) * 1990-09-10 1992-07-15 Abbott Lab Angiotensin ii receptor antagonists and pharmaceutical compositions containing them
US5250548A (en) * 1990-09-10 1993-10-05 Abbott Laboratories Angiotensin II receptor antagonists
FR2672892B1 (en) * 1991-02-20 1994-01-14 Synthelabo DERIVATIVES OF 4-PYRIMIDINONES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION.
US5472967A (en) * 1991-02-20 1995-12-05 Synthelabo 4-pyrimidinone derivatives their preparation and their application in therapy
DE4110019C2 (en) * 1991-03-27 2000-04-13 Merck Patent Gmbh Imidazopyridines, processes for their production and pharmaceutical preparations containing them
AU1625192A (en) * 1991-05-31 1992-12-03 Zeneca Limited Heterocyclic derivatives
IT1250749B (en) * 1991-08-02 1995-04-21 Luso Farmaco Inst HETEROCYCLIC COMPOUNDS ACTIVATED IN II ANTAGONIST
US5256781A (en) * 1991-10-24 1993-10-26 American Home Products Corporation Substituted quinazolines as angiotensin II antagonists
US5236925A (en) * 1991-10-24 1993-08-17 American Home Products Corporation Fused pyrimidines as angiotensin II antagonists
US5234936A (en) * 1991-10-24 1993-08-10 American Home Products Corporation Pyrimidocycloalkanes as a ii antagonists
DE4221583A1 (en) 1991-11-12 1993-05-13 Bayer Ag SUBSTITUTED BIPHENYLPYRIDONE
GB9125842D0 (en) * 1991-12-04 1992-02-05 Ici Plc Heterocyclic derivatives
US5225408A (en) * 1991-12-20 1993-07-06 E. R. Squibb & Sons, Inc. Biphenyl oxadiazinone angiotensin II inhibitors
IL104756A0 (en) * 1992-02-17 1993-06-10 Ciba Geigy Ag Composition for the treatment of glaucoma
US5378704A (en) * 1992-04-15 1995-01-03 E. R. Squibb & Sons, Inc. Non-peptidic angiotensin-II-receptor-antagonists
US5236916A (en) * 1992-05-26 1993-08-17 E. R. Squibb & Sons, Inc. Oxadiazinone substituted indole and benzimidazole derivatives
TW348175B (en) * 1993-01-06 1998-12-21 Hoechst Ag Process for the preparation of biphenyl derivatives
AU1522400A (en) 1998-11-12 2000-05-29 Elan Pharmaceuticals, Inc. Substituted pyrimidine compositions and methods of use
SE9903028D0 (en) 1999-08-27 1999-08-27 Astra Ab New use
CN101072783A (en) 2004-10-08 2007-11-14 寿制药株式会社 Phosphonic acid derivative and therapeutic agent for disease in which high phosphate level in blood participates
EP1869023B1 (en) * 2005-04-12 2012-01-11 Vicore Pharma AB New tricyclic angiotensin ii agonists
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EP2170930B3 (en) 2007-06-04 2013-10-02 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
JP2011522828A (en) 2008-06-04 2011-08-04 シナジー ファーマシューティカルズ インコーポレイテッド Guanylate cyclase agonists useful for the treatment of gastrointestinal disorders, inflammation, cancer, and other disorders
AU2009270833B2 (en) 2008-07-16 2015-02-19 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
WO2011105099A1 (en) * 2010-02-25 2011-09-01 興和株式会社 Compound containing a novel 4-alkoxypyridine formation and medicine containing same
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
WO2014151206A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
EP3004138B1 (en) 2013-06-05 2024-03-13 Bausch Health Ireland Limited Ultra-pure agonists of guanylate cyclase c, method of making and using same
CN116134025A (en) * 2020-09-17 2023-05-16 浙江海正药业股份有限公司 Amide phosphine oxide derivative and preparation method and application thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1334092C (en) * 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles

Also Published As

Publication number Publication date
IL96009A0 (en) 1991-07-18
HUT55383A (en) 1991-05-28
NO176758C (en) 1995-05-24
CA2027839A1 (en) 1991-04-20
EP0424317A2 (en) 1991-04-24
AU6468090A (en) 1991-04-26
NZ235726A (en) 1993-09-27
FI93957C (en) 1995-06-26
NO904511D0 (en) 1990-10-18
FI93957B (en) 1995-03-15
AU638496B2 (en) 1993-07-01
JPH03133964A (en) 1991-06-07
ZA908344B (en) 1991-06-26
HU906501D0 (en) 1991-04-29
NO176758B (en) 1995-02-13
PT95626A (en) 1991-09-13
MX22877A (en) 1993-12-01
IE903749A1 (en) 1991-04-24
FI905124A0 (en) 1990-10-17
KR910007889A (en) 1991-05-30
EP0424317A3 (en) 1991-09-25

Similar Documents

Publication Publication Date Title
NO904511D0 (en) Pyrimidine.
NO905350D0 (en) UTPORSJONERINGSAPPARAT.
NO902289L (en) BLODPROEVE-ROER.
DE69017059D1 (en) Multi-turntable.
DE59007379D1 (en) 3-phenylbenzofuran-2-one.
DE59007974D1 (en) Uretero-renoscope.
FI921930A0 (en) PULSFRI SIKT.
NO902053D0 (en) BESTRYKNINGSINNRETNING.
FI905886A0 (en) PLASMABEHANDLINGSFOERFARANDE OCH -ANORDNING.
NO890521D0 (en) SUBSTITUTED PYRIMIDINES.
DE69020950D1 (en) Multi-turntable.
DE59004522D1 (en) MICRODOSER.
DE59005135D1 (en) FORMSTEIN.
DE59008431D1 (en) Triazolylsulfonamides.
FI892094A0 (en) HOEGFREKVENSBANDPASSFILTER.
NO900540D0 (en) FISKEDAMKONSTRUKSJON.
DE69013427D1 (en) Glyoxyl-cyclohexenediones.
DE59008846D1 (en) FLUORPHENYLPYRIMIDINE.
FI903857A0 (en) STAPELPARKERINGSSYSTEM FOER FORDON.
FI902759A0 (en) MULTIVALSIG GRUPPVALSANORDNING.
DE59007719D1 (en) Pyrazole-3-carboxamides.
NO905240D0 (en) HAANDLAMPE.
DE69004844D1 (en) Pyrimidine derivatives.
DE69008037T2 (en) Saddlecloth.
DE69005107D1 (en) FOOTCROSS.